India now offers Awiqli, a new once-weekly basal insulin for diabetes patients. This drug reduces annual injections from 365 ...

India has become one of the first countries in the world to introduce Awiqli, the world's first once-a-week basal insulin ...

Novo Nordisk has launched Awiqli, the world's first once-weekly basal insulin, in India for adults with Type 1 and Type 2 diabetes. The shift from daily to weekly injections could ease treatment ...

Ecnoglutide, a novel once-weekly injection for type 2 diabetes management, works as well as dulaglutide (a commonly prescribed once-a-week injection to manage diabetes) in lowering blood sugar levels, ...